Editorial standards·Review board

DermatologyNewsAbout

Topic

Semaglutide

Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and weight management.

MedicalDermatologyNews

GLP-1 hair shedding: is it the drug or the weight loss?

Hair loss reported with semaglutide and tirzepatide: what the evidence shows about telogen effluvium, androgenetic alopecia, diagnosis, and recovery.

May 30, 2026 · 3 min · Medically reviewed

Three concerns and the treatment the reviews match to each: volume with hyaluronic acid filler (immediate cheek, temple and under-eye volume), dermal quality with polynucleotide injectables (not volume), and laxity with microfocused ultrasound or monopolar radiofrequency.

Ozempic face (GLP-1) facial volume loss: 2026 review

Why GLP-1 receptor agonists cause facial volume loss, severity predictors, and the published multimodal restoration approaches in 2026.

May 28, 2026 · 8 min · Medically reviewed